AB
Elite in Progressive Supranuclear Palsy
Check Dr. Adam L. Boxer's experience treating your condition:
About Dr. Adam L. Boxer

Adam Boxer is a Neurologist in San Francisco, California. Boxer has been practicing medicine for over 25 years and is rated as an Elite expert by MediFind in the treatment of Progressive Supranuclear Palsy. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Frontotemporal Dementia. He is licensed to treat patients in California.

His clinical research consists of co-authoring 246 peer reviewed articles and participating in 29 clinical trials in the past 15 years. In particular, he has co-authored 78 articles and participated in 15 clinical trials in the study of Progressive Supranuclear Palsy.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Adam L. Boxer it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
1651 4th St, Suite 212, San Francisco, CA 94158
Other Locations
400 Parnassus Ave, San Francisco, CA 94143
Background & Education
Graduate Institution
New York University School Of Medicine, 1998
Specialties
Neurology
Licenses
Psychiatry & Neurology in CA
Hospital Affiliations
UCSF Helen Diller Medical Center At Parnassus Heights
San Francisco Medical Center
UCSF Medical Center At Mount Zion
Chinese Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


25 Clinical Trials

Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia
The Four-Repeat Tauopathy Neuroimaging Initiative
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide (NAP, AL-108) in Predicted Tauopathies
An Open Label Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations
View 19 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished